BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang S, Xing N, Meng X, Xiang L, Zhang Y. Comprehensive bioinformatics analysis to identify a novel cuproptosis-related prognostic signature and its ceRNA regulatory axis and candidate traditional Chinese medicine active ingredients in lung adenocarcinoma. Front Pharmacol 2022;13:971867. [DOI: 10.3389/fphar.2022.971867] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang J, Shi J, Wu P, Sun W, Zhang D, Wang Z, Ji X, Lv C, Zhang T, Zhang P, Zhang H. Identification of a Novel Cuproptosis-Related Gene Signature and Integrative Analyses in Thyroid Cancer. J Clin Med 2023;12. [PMID: 36902801 DOI: 10.3390/jcm12052014] [Reference Citation Analysis]
2 Zhang B, Zhang T, Zheng Z, Lin Z, Wang Q, Zheng D, Chen Z, Ma Y. Development and validation of a cuproptosis-associated prognostic model for diffuse large B-cell lymphoma. Front Oncol 2022;12:1020566. [PMID: 36713586 DOI: 10.3389/fonc.2022.1020566] [Reference Citation Analysis]
3 Zhou J, Chen D, Zhang S, Wang C, Zhang L. Identification of two molecular subtypes and a novel prognostic model of lung adenocarcinoma based on a cuproptosis-associated gene signature. Front Genet 2022;13:1039983. [PMID: 36712848 DOI: 10.3389/fgene.2022.1039983] [Reference Citation Analysis]
4 Li Y, Zeng X. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma. Front Pharmacol 2022;13:1081952. [PMID: 36703728 DOI: 10.3389/fphar.2022.1081952] [Reference Citation Analysis]
5 Liu Y, Lin W, Yang Y, Shao J, Zhao H, Wang G, Shen A. Role of cuproptosis-related gene in lung adenocarcinoma. Front Oncol 2022;12:1080985. [PMID: 36620594 DOI: 10.3389/fonc.2022.1080985] [Reference Citation Analysis]
6 Li J, Du Q, Sun J, Xiang L, Wang S. Identification and validation of a novel phagocytosis regulators-related signature with potential prognostic and immunotherapeutic value in patients with lung adenocarcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.988332] [Reference Citation Analysis]